McGonagle, D. Et Al. 2017. Reply to: Behçet's disease: An MHC-I-opathy?. Clinical and Experimental Rheumatology , vol.35 , 6.

McGonagle, D., Aydin, S. Z., Gul, A., Mahr, A., & Direskeneli, H., (2017). Reply to: Behçet's disease: An MHC-I-opathy?. Clinical and Experimental Rheumatology , vol.35, 6.

McGonagle, D. Et Al. "Reply to: Behçet's disease: An MHC-I-opathy?," Clinical and Experimental Rheumatology , vol.35, 6, 2017

McGonagle, D. Et Al. "Reply to: Behçet's disease: An MHC-I-opathy?." Clinical and Experimental Rheumatology , vol.35, pp.6, 2017

McGonagle, D. Et Al. (2017) . "Reply to: Behçet's disease: An MHC-I-opathy?." Clinical and Experimental Rheumatology , vol.35, p.6.

@article{article, author={D. McGonagle Et Al. }, title={Reply to: Behçet's disease: An MHC-I-opathy?}, journal={Clinical and Experimental Rheumatology}, year=2017, pages={6} }